Endonovo Therapeutics, Inc. (OTCMKTS:ENDV) Short Interest Up 300.0% in March

Endonovo Therapeutics, Inc. (OTCMKTS:ENDV) was the target of a large growth in short interest in the month of March. As of March 15th, there was short interest totalling 400,000 shares, a growth of 300.0% from the February 28th total of 100,000 shares. Based on an average trading volume of 23,757,600 shares, the short-interest ratio is presently 0.0 days. Approximately 0.0% of the shares of the company are sold short.

Endonovo Therapeutics Stock Performance

Shares of ENDV stock traded down $0.00 on Thursday, reaching $0.00. The stock had a trading volume of 97,249,932 shares, compared to its average volume of 32,224,309. Endonovo Therapeutics has a 1 year low of $0.00 and a 1 year high of $0.01.

About Endonovo Therapeutics

Endonovo Therapeutics, Inc, a biotechnology company, develops, manufactures, and distributes non-invasive Electroceutical medical devices for regenerative medicine. The company offers SofPulse, a non-invasive Electroceutical therapeutic device for the palliative treatment of soft tissue injuries, chronic wounds, and post-operative pain and edema.